Merck Launches EdiMembre to Advance Cultivated Meat Tech

Merck Launches EdiMembre to Advance Cultivated Meat Tech

India Pharma Outlook Team | Tuesday, 19 August 2025

Merck  a global leader in science and technology  is  partnered with company builder mantro GmbH (Munich, Germany) to accelerate the establishment of EdiMembre, a Deep-Tech spin-out from Massachusetts, U.S.A., that is poised to disrupt the alternative protein sector.

“Cultivated meat, a core focus in the alternative protein market, offers a powerful solution for sustainability and global food security. To meet urgent market needs, the development of structured meat products that replicate the texture and complexity of conventional meat is essential.

Leveraging its pioneering technology and patent portfolio, Merck enabled the creation of a dedicated spin-out to develop a market-ready product, unlocking access to this breakthrough and empowering clients and investors to shape the future of food together,” said Laura Matz, Group Science & Technology Officer at Merck, explaining the strategic importance of EdiMembre’s mission.

“The formation of EdiMembre represents a significant milestone in the alternative protein industry. By combining Merck’s advanced technology with mantro’s company building expertise and strong investor backing, we have created a powerhouse capable of driving real change in sustainable food production. I am thrilled to be part of this journey and confident in our ability to make a lasting impact,” said Manfred Tropper, CEO of mantro and new non-executive board member at EdiMembre.

Also Read: Cohance Lifesciences to Invest $10 Million in US Bioconjugation Expansion

Building on Merck's Deep-Tech foundation, EdiMembre expands the uses of the edible membrane technology platform, which has been developed in recent years and is essential for the development of complex tissue structures needed for the scalable production of structured cultured meat. At the same time, the platform technology has been used to investigate high-protein, plant-based pasta applications. EdiMembre is armed with a strong patent portfolio, great people, and good business partnerships to bring its sustainable alternative protein solutions to market quickly.

on the deck

Most Viewed

Related Articles


© 2025 India Pharma Outlook. All Rights Reserved.